B
ONC

Barings’s BeOne Medicines Ltd ONC Stock Holding History

Barings’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Hold
42,815
– – 0.22% 46
2026
Q1 		$12.7M Hold
42,815
– – 0.21% 46
2025
Q4 		$13M Sell
42,815
-12,789
-23% -$4.19M 0.24% 42
2025
Q3 		$18.9M Hold
55,604
– – 0.36% 33
2025
Q2 		$13.5M Hold
55,604
– – 0.31% 33
2025
Q1 		$15.1M Sell
55,604
-15,818
-22% -$3.7M 0.38% 35
2024
Q4 		$13.2M Buy
71,422
+3,424
+5% +$700K 0.31% 35
2024
Q3 		$15.3M Buy
67,998
+16,235
+31% +$2.92M 0.36% 30
2024
Q2 		$7.39M Buy
51,763
+20,663
+66% +$3.18M 0.18% 51
2024
Q1 		$4.86M Sell
31,100
-29,279
-48% -$4.71M 0.12% 80
2023
Q4 		$10.9M Buy
+60,379
New +$10.9M 0.35% 33
2021
Q4 		– Sell
-924
Closed -$335K – 405
2021
Q3 		$335K Buy
+924
New +$302K 0.01% 295
2020
Q1 		– Sell
-17,842
Closed -$2.96M – 640
2019
Q4 		$2.96M Sell
17,842
-872
-5% -$145K 0.08% 198
2019
Q3 		$2.29M Sell
18,714
-44,767
-71% -$5.95M 0.05% 237
2019
Q2 		$7.87M Sell
63,481
-305
-0.5% -$38.7K 0.17% 118
2019
Q1 		$8.42M Sell
63,786
-66,385
-51% -$8.96M 0.19% 89
2018
Q4 		$18.3M Buy
130,171
+31,915
+32% +$4.23M 0.32% 57
2018
Q3 		$16.9M Sell
98,256
-54,648
-36% -$9.19M 0.24% 74
2018
Q2 		$23.5M Buy
152,904
+39,848
+35% +$7.11M 0.33% 52
2018
Q1 		$19M Buy
+113,056
New +$15.3M 0.27% 59

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Barings's ONC Position: Q2 2026 in Review

Barings held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 42,815 shares worth $12.2M. The position accounts for 0.22% of the portfolio, ranked #46.

Barings first reported a position in ONC in Q1 2018 and has held it in 20 quarters since. The position peaked at $23.5M in Q2 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Barings held 42,815 shares of BeOne Medicines Ltd worth $12.2M as of Q2 2026.
  • Barings left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 0.22% of Barings's portfolio in Q2 2026, its #46 holding.
  • Barings first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 20 quarters since.
  • Barings's BeOne Medicines Ltd position peaked at $23.5M in Q2 2018.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Barings's 13F filing for Q2 2026, filed 7 Aug 2026.